Adverse Events of Menin Inhibitors in AML: What Nurses Should Know
Ivonescimab/Chemo Ups PFS After Third-Generation TKI in EGFR+ NSCLC
Proactive Nursing Care for PI3K and AKT Inhibitor Adverse Effects
Subcutaneous Daratumumab Reduces Smoldering Myeloma Progression